HongShan, IDG & Hillhouse Said to Lead ByteDance’s AI Drug Discovery Spin-off
17 Sep 2026
US$ 20.00
HongShan Capital Group, IDG Capital and Hillhouse Investment Management reportedly have jointly led the US$290 m debut...
Related Publications
Subscribers’ Weekly for the week ending 18 Sep 2026...
Listen to Subscribers' Weekly 18 Sep 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.